Metformin mitigates amyloid β1-40-induced cognitive decline via attenuation of oxidative/nitrosative stress and neuroinflammation
Authors:
- 1 February 2023
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 38 (4) , 1127-1142
Abstract
Metformin is an antidiabetic medicine widely used for management of type 2 diabetes with neuroprotective effects and promising potential to attenuate cognitive impairment. The efficacy of metformin in attenuation of Alzheimer’s disease (AD) pathology has not been well-documented. Thus, this study was designed to assess protective effect of metformin against Aβ1−40-instigared cognitive impairment. After intra-CA1 microinjection of aggregated Aβ1−40, rats received oral metformin (50 and/or 200 mg/kg/day) for two weeks. Cognition function was analyzed in various behavioral tasks besides measurement of hippocampal oxidative stress, apoptosis, and inflammation along with H&E staining and 3-nitrotyrosine (3-NT) immunohistochemistry. Obtained data showed significant improvement of discrimination score in novel object recognition test, higher alternation score in Y maze, greater latency in passive avoidance task, and lower working and reference memory errors in radial arm maze in metformin-treated Aβ-injured group. Moreover, metformin treatment attenuated hippocampal levels of nitrite, MDA, protein carbonyl, ROS, TNFα, GFAP, DNA fragmentation intensity, caspase 3 activity, AChE activity, and increased SOD activity and level of IL-10 as an anti-inflammatory factor. In addition, metformin treatment was associated with lower CA1 neuronal loss and it also decreased intensity of 3-NT immunoreactivity as an indicator of nitrosative stress. Taken together, obtained findings showed neuroprotective and anti-dementia property of metformin in male rats and this may have potential benefit in attenuation of cognitive decline and related complications in patients with neurodegenerative disorders such as AD besides diabetes mellitus.Keywords
Funding Information
- Shahed University (p-647-89)
This publication has 87 references indexed in Scilit:
- Effects of metformin and other biguanides on oxidative phosphorylation in mitochondriaBiochemical Journal, 2014
- Metformin-inclusive Therapy Reduces the Risk of Stroke in Patients with Diabetes: A 4-Year Follow-up StudyJournal of Stroke and Cerebrovascular Diseases, 2014
- Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 MiceJournal of Neuropathology & Experimental Neurology, 2013
- The novel object recognition memory: neurobiology, test procedure, and its modificationsCognitive Processing, 2011
- Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 DiabetesDiabetes Care, 2009
- Aβ-mediated activation of the apoptotic cascade in cultured cortical neurones: a role for cathepsin-LNeurobiology of Aging, 2004
- Improving the thiobarbituric acid-reactive-substances assay for estimating lipid peroxidation in plant tissues containing anthocyanin and other interfering compoundsPlanta, 1999
- [38] Oxidative damage to proteins: Spectrophotometric method for carbonyl assay1994
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961